Viewing Study NCT00675012


Ignite Creation Date: 2025-12-26 @ 11:10 AM
Ignite Modification Date: 2026-05-17 @ 7:28 PM
Study NCT ID: NCT00675012
Status: COMPLETED
Last Update Posted: 2014-05-30
First Post: 2008-05-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer
Sponsor: AGC Biologics S.p.A.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colon Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NGR-hTNF View
None Capecitabine View
None Oxaliplatin View
None Colon cancer View